BDX teams up with the Penn Institute for Immunology and Immune Health to launch a high-parameter immune profiling study.
Becton Dickinson (BDX) just doubled down on immune system science by teaming up with the University of Pennsylvania’s Institute for Immunology and Immune Health to build advanced flow cytometry panels ...
Chronic stress and poor sleep may weaken immunity by reducing natural killer cells, a new study finds, highlighting the ...
IGIB, has launched India's first Centre of Excellence for Single-Cell Multiomics to enhance research in immunity, cancer, and ...
Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...
BD Biosciences and CSIR- IGIB inaugurate its first centre of excellence for single-cell multiomics: Our Bureau, Mumbai Tuesday, December 23, 2025, 17:45 Hrs [IST] BD Life Sciences ...
Adaptive workflow systems represent a significant departure from rigid, process-centric approaches. Instead of imposing a linear, step-by-step structure, teams will be able to dynamically assign and ...
Human immunodeficiency virus (HIV) infections are still fairly common and an estimated 40 million people worldwide are ...
While most of us were hopping from one Christmas party to another on Dec. 18, our columnist Dr. Raymundo W. Lo was doing something else ...
Atomic defects in nanodiamonds enable both precise heating of lysosomes inside macrophages and nanoscale temperature ...
Artificial intelligence-supported cell imaging could help laboratories to set defensible quality thresholds for living ...
Lisocabtagene maraleucel (liso-cel) shows high response rates in heavily pretreated patients with relapsed or refractory chronic lymphocytic leukemia (CLL), with a CR/CRu rate of 60% and ORR of 83.3%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results